PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Collaborative team earns five-year renewal grant from NINDS to continue stroke research

2025-09-12
(Press-News.org)

Stroke research aims to understand the brain’s self-protective and repair mechanisms. Gaining detailed insight into these mechanisms is crucial as such knowledge could lead to newly developed medications and interventions which mimic or engage the brain’s self-protective/repair mechanisms, leading to innovative stroke therapies.

In 2018 the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH) awarded a five-year, $2.9 million R01 grant (“Development and characterization of peptidomimetic small molecule activators of peptidase neurolysin for stroke therapy”) to a research team from Texas Tech University Health Sciences Center (TTUHSC) in Amarillo to help uncover and develop much needed therapies for the treatment of ischemic stroke. The team for this RO1 project included multiple principal investigators (PIs; project leaders) from TTUHSC’s Department of Pharmaceutical Sciences: Thomas Abbruscato, Ph.D., who serves as department chair, director of TTUHSC’s Brain Drug Discovery Research Center and senior associate dean for the TTUHSC Graduate School of Biomedical Sciences; Vardan Karamyan, Ph.D., (contact PI); and Paul Trippier, Ph.D.

Because of the COVID-19 pandemic and PIs moving to other institutions (Trippier moved his research group to the University of Nebraska in 2019, and Karamyan moved to Oakland University’s Beaumont School of Medicine in 2022), the team was able to extend the grant from five to seven years. Despite the logistical changes, their collaborative work still produced 29 experimental, conceptual and review publications related to the project and two patents.

Due to this high level of productivity and potential to create new medications for stroke injury, NINDS recently awarded a new $3 million competitive renewal that extends the grant for an additional five years to 2030, something Abbruscato said is often considered more difficult to do than earning the initial grant.

“Competitive renewal grants are even harder to get because you've had all this support already — the NIH already awarded us a substantial amount of support to do this original work — so the expectations are a little higher and you have to show strong productivity for a competitive renewal,” Abbruscato explained. “In this case, the NIH has invested in our program for years, so for them, they would like only to continue the work if we showed strong progress. It also helped that we had a strong study section review score of 7% on this competitive renewal application.”

Supported by the new competitive renewal grant, Abbruscato said the team will continue its collaborative efforts to accomplish three well-integrated aims. The first specific aim is to apply medicinal chemistry techniques for lead compound optimization, which will be conducted by Trippier’s lab to further refine the activity and drug-like properties of neurolysin (Nln) activators. In previous research, the team identified Nln as a leading self-protective mechanism in the brain that helps prevent cerebral neuron damage and aids in recovery after stroke.

“This is where we take our lead compounds from Dr. Trippier’s lab that have the best pharmaceutical properties, such as blood-brain barrier penetration, stability and protein binding,” Abbruscato said. “We want to find out if they are stable in the bloodstream and brain, and if they enter into the stroke injury part of the brain. We also look at protein binding, which is very important to make sure there's a free fraction of the compound available to activate the enzyme of interest in the brain. In this case, Nln is the lead enzyme we're trying to activate.”

The project’s second aim is to perform biochemical and structural studies to characterize the activation mechanism(s) targeted by the identified Nln activators. For the biochemical studies, Trippier sends the best candidate compounds to the Karamyan and Abbruscato labs for characterization using in vitro models (outside a living organism, such as using a test tube or culture dish).

“We do an iterative (i.e., computational or mathematical) process where we start with just models,” Abbruscato said. “Dr. Karamyan has a system where you can look at how much the candidate compound activates a pure enzyme. In our lab, we look at blood-brain barrier properties in vitro to find out how these compounds cross the blood-brain barrier and if they are restricted. We’re trying to estimate how much of that new molecule is going to enter into the brain and determine if it truly is at a brain concentration that can activate the enzyme.”

The structural studies related to the project’s second aim will be conducted by co-investigator Benjamin Orlando, Ph.D., from Michigan State University. He will study how Nln and other compound candidates bind to the enzyme. 

“These structural experiments were important in our grant renewal because we presented an actual cryo-EM (Cryogenic electron microscopy) image from Dr. Orlando’s laboratory of our target enzyme, Nln, which uncovers the structural components of the enzyme and ligand that are important for activation,” Abbruscato said. “This means we can see exactly which components of the structure are important for activation, and this helps to inform Dr. Trippier in his synthesis of novel compounds.”

The project’s third aim involves characterizing the effectiveness of the drugs in preclinical models of stroke. During this process, the research team will test their best compounds in two models of stroke. Karamyan uses one model known as distal MCAO, a photothrombotic model used to induce a mild ischemic stroke. Abbruscato’s lab will test the same compounds in another model of middle cerebral artery occlusion model, which is a more severe model of stroke. 

Abbruscato said using two preclinical models strengthens the study because people can test new molecules in both mild and severe stroke injury models.

“The fact that we're confirming these molecules in two separate labs also makes the work more robust, which was also important in getting the grant renewal,” Abbruscato said. “Our ultimate long-term goal is to translate the lead Nln activators from bench to bedside and ultimately develop an effective stroke therapy, which could transform the current treatment modalities for a vast number of stroke patients.” 

###

END



ELSE PRESS RELEASES FROM THIS DATE:

Vitamin K analogues may help transform the treatment of neurodegenerative diseases

2025-09-12
Neurodegenerative diseases like Alzheimer’s, Parkinson’s, and Huntington’s disease are characterized by the progressive loss of neurons. The resulting debilitating symptoms, such as loss of memory and cognition, and motor impairment, can significantly degrade patients’ quality of life, confining them to round-the-clock care. While currently used drugs help alleviate symptoms, curative treatments are lacking, thus underscoring the need for novel therapeutic strategies. One such strategy involves the induction of neuronal differentiation, which can replenish lost neurons and ...

Cyclic triaxial tests: Evaluation of liquefaction resistance in chemically treated soils

2025-09-12
Soil liquefaction can be a major threat to the infrastructure and built environments in an earthquake-prone area. This happens due to substantial loss of soil stiffness and strength due to applied stress. Loose, moderately granulated, sandy soil is more prone to soil liquefaction. Recognizing the urgent need to enhance urban resilience in seismic-prone regions, particularly in rapidly urbanizing areas vulnerable to such hazards, scientists are focusing on different mitigation techniques. Soil compaction technique ...

Uniting the light spectrum on a chip

2025-09-12
Focused laser-like light that covers a wide range of frequencies is highly desirable for many scientific studies and for many applications, for instance quality control of manufacturing semiconductor electronic chips. But creating such broadband and coherent light has been difficult to achieve with anything but bulky energy-hungry tabletop devices. Now, a Caltech team led by Alireza Marandi, a professor of electrical engineering and applied physics at Caltech, has created a tiny device capable of producing an unusually wide range of laser-light ...

Hundreds of new bacteria, and two potential antibiotics, found in soil

2025-09-12
Most bacteria cannot be cultured in the lab—and that’s been bad news for medicine. Many of our frontline antibiotics originated from microbes, yet as antibiotic resistance spreads and drug pipelines run dry, the soil beneath our feet has a vast hidden reservoir of untapped lifesaving compounds. Now, researchers have developed a way to access this microbial goldmine. Their approach, published in Nature Biotechnology, circumvents the need to grow bacteria in the lab by extracting very large DNA fragments directly from soil to piece together the genomes of previously hidden microbes, and then mines resulting genomes for ...

Smells deceive the brain – are interpreted as taste

2025-09-12
Flavoured drinks without sugar can be perceived as sweet – and now researchers know why. A new study from Karolinska Institutet in Sweden, published in the journal Nature Communications, reveals that the brain interprets certain aromas as taste. When we eat or drink, we don’t just experience taste, but rather a ‘flavour’. This taste experience arises from a combination of taste and smell, where aromas from food reach the nose via the oral cavity, known as retronasal odour. Researchers at Karolinska Institutet have now shown that the brain integrates these signals earlier than previously thought – already in the insula, ...

New species survival commission fills critical gap in conservation

2025-09-12
A newly-formed group of scientists will be fighting for the survival of species — the smallest ones on the planet.   The International Union for Conservation of Nature (IUCN) has launched a species survival commission for microbiology and microbes to serve as a global safeguard for microbial biodiversity and to pursue coordinated conservation action. The new Microbial Conservation Specialist Group marks a first in the history of international conservation and filling a critical gap in ...

New conservation committee led by Applied Microbiology International calls on science community to get on board with microbial conservation

2025-09-12
The team behind a new world-leading conservation committee headed by Applied Microbiology International (AMI) is calling on global scientific and conservation communities to get on board to protect microbial life. Members of the new IUCN Microbial Conservation Specialist Group (MCSG) have outlined its priorities for its first year and beyond in a paper published in Nature Microbiology. Earlier this year, global conservation leader, the International Union for the Conservation of Nature (IUCN) officially approved ...

Scientists uncover key stabilizing role of small molecules

2025-09-12
For decades, amino acids have been added to medical formulations like insulin as stabilizers: these small molecules keep proteins (i.e. larger particles) from interacting in undesirable ways. And for decades, scientists have known that this works – but not why. Now, an international team of scientists, led by the Supramolecular Nano-Materials and Interfaces Laboratory in EPFL’s School of Engineering, has finally explained the ‘why’ – and in the process, unearthed a fundamental stabilizing effect ...

“Black Hole Stars” could solve JWST riddle of overly massive early galaxies

2025-09-12
In the summer of 2022, less than a full month after the James Webb Space Telescope (JWST) had begun to produce its first scientific images, astronomers noticed something unexpected: little red dots. In pictures taken at JWST’s unprecedented sensitivity, these extremely compact, very red celestial objects showed very clearly on the sky and there appeared to be a considerable number of them. JWST had apparently discovered a whole new population of astronomical objects, which had eluded the Hubble Space Telescope. That latter part is unsurprising. “Very red” ...

Mysterious ‘red dots’ in early universe may be ‘black hole star’ atmospheres

2025-09-12
UNIVERSITY PARK, Pa. — Tiny red objects spotted by NASA's James Webb Space Telescope (JWST) are offering scientists new insights into the origins of galaxies in the universe — and may represent an entirely new class of celestial object: a black hole swallowing massive amounts of matter and spitting out light. Using the first datasets released by the telescope in 2022, an international team of scientists including Penn State researchers discovered mysterious “little red dots.” The researchers suggested the objects may be galaxies that were as mature as our current Milky Way, which is roughly 13.6 billion years ...

LAST 30 PRESS RELEASES:

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

Psychiatry, primary care, and OB/GYN subspecialties hit hardest by physician attrition

New Canadian study reveals where HIV hides in different parts of the body

Lidocaine poisonings rise despite overall drop in local anesthetic toxicity

Politics follow you on the road

Scientists blaze new path to fighting viral diseases

The mouse eye as a window to spotting systemic disease

AI and the Future of Cancer Research and Cancer Care to headline October 24 gathering of global oncology leaders at the National Press Club: NFCR Global Summit to feature top scientists, entrepreneurs

FDA clears UCLA heart tissue regeneration drug AD-NP1 for clinical trials

Exploring the therapeutic potential of cannabidiol for Alzheimer's

We need a solar sail probe to detect space tornadoes earlier, more accurately, U-M researchers say

Acute myeloid leukemia (AML): Disease risk but not remission status determines transplant outcomes – new ASAP long-term results

Sperm microRNAs: Key regulators of the paternal transmission of exercise capacity

Seeing double: Clever images open doors for brain research

Inhaler-related greenhouse gas emissions in the US

UCLA Health study finds inhalers for asthma and COPD drive significant greenhouse gas emissions

A surgical handover system for patient physiology and safety

[Press-News.org] Collaborative team earns five-year renewal grant from NINDS to continue stroke research